| Value | ₹80.35 Cr |
|---|
BSE filing, NSE: MAXIND. Summary written from the filing by ALFA Finder's alert engine.
Max India Ltd: key numbers
- Share price
- ₹145.25
- Market cap
- ₹818.1 Cr
- Revenue (annual)
- ₹190.6 Cr
- Net profit (annual)
- ₹-121.8 Cr
- P/E (TTM)
- -6.8×Sector 21.3×
- Promoter holding
- 48.22%-1.55% QoQ
- FII holding
- 6.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max India Ltd
All →Max India Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹95.5 Cr (+90% YoY) and beta loss narrowed to ₹11.4 Cr, but the group is still loss-making. Management leans on lumpy residential fees and repeatedly reframed breakeven timelines.
Max India Other Announcement
Max India filed a CARE Ratings monitoring agency report for the quarter ended September 2026. It reports no deviation from the objects of its rights issue.
Max India Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs 95.5 Cr (+90% YoY), EBITDA loss narrowed to Rs 11.4 Cr from Rs 25.3 Cr, net loss Rs 22.3 Cr. Residences, Care Homes and AGEasy all scaling; management frames a path to profitability.
Max India Q2 FY27 Results: Net Loss of ₹22.2 Cr, Loss Narrows
Max India Ltd reported revenue from operations of ₹86.8 Cr (+92.0% YoY) and a net loss of ₹22.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹22.2 Cr
Max India Board Meeting Date
Max India Ltd will hold its Board meeting on November 3, 2026, to consider un-audited Q1 and H1 results. Trading window closes after results announcement.
Max India Business Update
Max India's subsidiary Antara Senior Care handed over 200 apartments at its Noida senior-living community. The milestone advances the 340-unit Phase 1 project in Sector 150, Noida.
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr